Sign In
Buy DNMR
$0.350
+0 (+0%)
At Close: Feb 20, 2026
Danimer Scientific Announces $15 Million Registered Direct Offering
09:15pm, Wednesday, 20'th Mar 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (the “Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and pr
Danimer Scientific Announces Preliminary Fourth Quarter and Full Year 2023 Results
08:30am, Wednesday, 20'th Mar 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of
Danimer Scientific Announces Successful Expansion of Rinnovo® Demonstration Plant Capacity
08:30am, Thursday, 22'nd Feb 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)---- $DNMR--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and pro
Danimer Scientific Receives Continued Listing Standard Notice from NYSE
05:00pm, Monday, 29'th Jan 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the production of biodegradable
Danimer Scientific Announces New Directors
04:30pm, Thursday, 18'th Jan 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)---- $DNMR--Danimer Scientific has appointed Dr. David Moody and Mr. Richard Altice as members of Danimer's Board of Directors.
Danimer Scientific, Inc. (DNMR) Q3 2023 Earnings Call Transcript
07:03pm, Tuesday, 14'th Nov 2023
Danimer Scientific, Inc. (NYSE:DNMR ) Q3 2023 Earnings Call Transcript November 14, 2023 4:30 PM ET Company Participants James Palczynski - IR Steve Croskrey - Chairman and CEO Mike Hajost - CFO Confe
Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Misses Revenue Estimates
06:47pm, Tuesday, 14'th Nov 2023
Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.30 per share a year ago.
Danimer Scientific Announces Third Quarter 2023 Results
04:01pm, Tuesday, 14'th Nov 2023
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next-generation bioplastics company focused on the development and production of
Why Earnings Season Could Be Great for Danimer Scientific (DNMR)
09:47am, Thursday, 09'th Nov 2023
Danimer Scientific (DNMR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Danimer Scientific Announces Release Date for Third Quarter 2023 Results
12:17pm, Tuesday, 07'th Nov 2023
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production o
Danimer Scientific (DNMR) Expands Partnership With CPChem
12:47pm, Thursday, 21'st Sep 2023
Danimer Scientific (DNMR) and CPChem collaborate again to explore numerous high-volume polymer applications utilizing Rinnovo materials.
Danimer Scientific Announces Release Date for Second Quarter 2023 Results
07:30am, Monday, 31'st Jul 2023
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production o
Danimer Scientific to Present at TD Cowen Sustainability Week Conference
12:00pm, Wednesday, 07'th Jun 2023
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next-generation bioplastics company focused on the development and production of
Danimer Scientific, Inc. (DNMR) Q1 2023 Earnings Call Transcript
09:37pm, Wednesday, 10'th May 2023
Danimer Scientific, Inc. (NYSE:DNMR ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants James Palczynski - IR Stephen Croskrey - CEO & Chairman Michael Hajost - CFO Confere
Danimer Scientific, Inc. (DNMR) Reports Q1 Loss, Misses Revenue Estimates
06:59pm, Wednesday, 10'th May 2023
Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.26 per share a year ago.
